1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

A Cautionary Tale for All Labs

Discussion in 'CSI Laboratories' started by Anonymous, Feb 28, 2013 at 3:05 PM.

  1. Anonymous

    Anonymous Guest

    This from the Bioreference site:

    Originally Posted by MY CHEMICAL ROADRACE
    http://thestreetsweeper.org/undersur...Shock_Therapy_

    WOW!!! Other labs on this site had better pay attention to this too. Pushing needless and more expensive testing is going to come back and bite them big time.